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Neste trabalho relatamos o uso de nitratos de lantanídeos [Ln(NO3)3] atuando como catalisador 
na síntese de uma única etapa de derivados de 3-benzoíla- e 3-acetila-1,2,4-oxadiazóis a partir de 
cetonas, nitrilas e ácido nítrico. Este é o primeiro exemplo da síntese em única etapa de preparação 
de derivados benzoíla e acetila-1,2,4-oxadiazóis, usando acetofenonas com grupos doadores de 
elétrons.
In this work we report the use of lanthanide nitrates [Ln(NO3)3] acting as catalyst in direct one-
pot synthesis of 3-benzoyl- and 3-acetyl-1,2,4-oxadiazoles derivatives from ketones, nitriles and 
nitric acid. This is the first example of one-pot synthesis of benzoyl- and acetyl 1,2,4-oxadiazoles 
derivatives preparation using acetophenones derivates with electron-donator groups.
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Introduction
Lanthanide compounds have been extensively used as 
Lewis acids in the different reactions including asymmetric 
catalysis. The most important compounds include the 
use of chlorides,1 triflates,2 p-toluenesulphonates,3 
dithiocarbamates complexes,4 alkoxides5 and others.6 On 
the other hand, the oxadiazole group is a key element 
of a number of biological activity such as ligands of 
benzodiazepine receptor,7 inhibidor of protein tyrosine 
phosphatase,8 agonists of muscarinic receptors,9 anti-
inflammatory agents,10 antiviral agents,11 cardiovascular12 
and other medicinal activity.13 Also, 1,2,4-oxadiazole 
compounds have been applied as ligands of metal 
complexes14 and liquid crystalline materials.15,16 
Synthesis of 1,2,4-oxadiazole derivatives by using 
ketones, nitriles and nitric acid as starting materials and 
Fe(NO3)3 as catalyst has been reported by Itoh et al.
17 
However, this method has the disadvantage of low reaction 
rates and drastic conditions, resulting in low reaction 
yields. Recently, yttrium triflate [Y(OTf)3]
18 was applied 
instead of Fe(NO3)3 by using the same reaction condition 
in the synthesis of various 1,2,4-oxadiazole with low 
reaction times and good yields. Nonetheless, neither of 
these methodologies could be successfully applied in the 
synthesis of 1,2,4-oxadiazole contained electron-donating.
 In the present work, we have proposed a simple 
methodology for the one-pot synthesis of 1,2,4-oxadiazole 
derivates, by using lanthanide nitrates prepared in situ as 




All reagents were commercially available and used 
without any purification. 1H and 13C NMR spectra were 
recorded on a Varian 300-MHz spectrometer. Mass 
spectrometer spectra were recorded on a Shimadzu 
GC-MS-QP 5000 gas chromatograph-mass spectrometer 
equipped with a 30 m × 0.25 mm × 0.25 mm capillary 
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column of fused silica, Supelco Simplicity 1TM. All reactions 
were monitored by TLC. Flash column chromatography 
was carried out using 200-300 mesh silica gel at increased 
pressure.
Representative experimental procedure for synthesis of 
3,5-substituted-1,2,4-oxadiazole compounds by use of 
lanthanide oxides
In a typical procedure, the lanthanide oxides (0.3 mmol) 
and nitric acid (0.3 mmol) were stirred at 50 oC and then was 
added the ketone (3 mmol). After 10 min the appropriated 
nitrile (1 mL) was added and the result mixture stirred 
at 80 oC for the appropriate time (Table 3). The reaction 
mixture was quenched with NaHCO3 and the product was 
repeatedly extracted with ethyl acetate. The combined 
organic phases were dried over anhydrous MgSO4, followed 
by evaporation of the solvent under reduced pressure. 
The purification of the residue was performed using flash 
column chromatography (silica gel, EtOAc-cyclohexane 
10:90). All the products were identified by comparison of 
their spectral data and physical properties with authentic 
sample. The compounds 1, 2, 8 and 9 were characterized 
by comparison with spectral date reported in the literature 
date.17,18
Characterization data for representative compounds
3-(4-Bromobenzoyl)-5-phenyl-1,2,4-oxadiazole (3)
1H NMR (300 MHz, CDCl3) d 8.26 (dd, 2H, J 7.5, 
2.5 Hz), 8.24 (dd, 2H, J 7.6, 2.5 Hz), 7.71 (d, 2H, J 8.5 Hz), 
7.67 (t, 1H, J 7.0 Hz), 7.57 (t, 2H, J 7.5 Hz). 13C NMR 
(75 MHz, CDCl3) d 181.9, 176.7, 166.0, 133.8, 133.6, 
132.1, 132.1, 130.3, 129.3, 128.5, 123.2. MS (EI): m/z (%) 
329.9 (17) [M+], 280.9 (46), 206.9 (100), 182.8 (71), 154.8 
(34), 104.9 (71), 76.9 (37), 51.0 (17).
3-Benzoyl-5-phenyl-1,2,4-oxadiazole (4)
1H NMR (300 MHz, CDCl3) d 8.34 (d, 1H, J 8.5 Hz), 
8.27 (d, 1H, J 8.5 Hz), 7.71 (t, 2H, J 7.5 Hz), 7.65 (t, 2H, 
J 7.5), 7.51 (q, 2H, J 7.5 Hz). 13 C NMR (75 MHz, CDCl3) 
d 123.4, 128.5, 128.7, 129.2, 130.7, 133.4, 134.6, 135.1, 
166.2, 176.5, 183.1. MS (EI): m/z (%) 250.1 (3) [M+], 145.1 
(9), 105.1 (100), 77.0 (37), 51 (10).
3-(4-Methylbenzoyl)-5-phenyl-1,2,4-oxadiazole (5) 
1H NMR (300 MHz, CDCl3) d 8.26 (dd, 2H, J 8.5, 
1.5 Hz), 7.65 (t, 1H, J 7.0 Hz), 7.59 ( t, 2H, J 8.0 Hz), 7.36 
(d, 2H, J 8.5 Hz), 2.46 (s, 3H). 13C NMR (75 MHz, CDCl3) 
d 182.6, 176.4, 166.3, 145.9, 133.4, 132.7, 130.8, 129.5, 
128.5, 123.4, 21.8. MS (EI): m/z (%) 264.1 (8) [M+], 239.1 
(1), 159.1 (5), 147.1 (4), 136.1 (2), 119.1 (100), 105.1 (51), 
91.0 (27), 77.0 (23), 65.0 (10), 51.0 (6).
3-(4-Methoxybenzoyl)-5-phenyl-1,2,4-oxadiazole (6)
1H NMR (300 MHz, CDCl3) d 8.36 (dd, 2H, J 6.5 
Hz), 7.64 (t, 1H, J 6.5 Hz), 7.58 (t, 2H, J 6.5 Hz), 7.03 (d, 
2H, J 7.0 Hz), 3.92 (s, 3H). 13C NMR (75 MHz, CDCl3) 
d 181.3, 176.3, 166.4, 164, 9, 133.3, 133.3, 129.2, 128.5, 
128.2, 123.5, 114.1, 55.6. MS (EI): m/z (%) 280 (22) [M+], 
206.9 (4), 174.9 (12), 160.9 (5), 146.9 (10), 135.1 (100), 
121.1 (3), 105.1 (54), 92 (10), 77.0 (44), 63.0 (9), 51.0 (11).
3-(4-Nitrobenzoyl)-5-phenyl-1,2,4-oxadiazole (7)
1H NMR (300 MHz, CDCl3): d 8.55 (d, 2H, J 7 Hz), 8.40 
(d, 2H, J 9 Hz), 8.27 (d, 2H, J 7 Hz), 7.69 (t, 1H, J 7 Hz), 
7.60 ( t, 2H, J 7.50 Hz). 13C NMR (75 MHz, CDCl3): 
d 181.4, 177.1, 165.9, 151.1, 139.5, 133.8, 131.8, 129.4, 
129.3, 128.61, 123.0. MS (EI): m/z (%) 295.1 (17) [M+], 
149.9 (40), 120.1 (8) 105.1 (100), 92.0 (14), 77.0 (35), 
76.0 (16), 51.0 (10).
3-(4-Methylbenzoyl)-5-methyl-1,2,4-oxadiazole (10)
1H NMR (300 MHz, CDCl3) d 8.14 (d, 2H, J 6.5 Hz), 
7.34 (d, 2H, J 8 Hz), 2.73 (s, 3H), 2.46 (s, 3H). 13C NMR 
(75 MHz, CDCl3): d 182.4, 177.4, 165.8, 145.8, 132.6, 
130.7, 129.5, 21.8, 12.3. MS (EI): m/z (%) 202.1 (9) [M+], 
177.1 (1), 160.1 (10), 145.1 (2), 132.1 (10), 119.1 (100), 
104.1 (2), 91.0 (32), 77.0 (3), 65.0 (12), 51.0 (3).
Results and Discussion
In a preliminary screening, we carried out the reaction 
of benzonitrile, using europium nitrate prepared in situ 
from europium oxide or from europium dithiocarbamate 
with nitric acid and 4-chloroacetophenone at 80 oC. The 
results are compared with those obtained from the europium 
triflate and were shown in Table 1.
All of the three europium compounds gave similar 
yields; however, the reactions with europium nitrate and 
europium ditiocarbamate were faster than those with 
europium triflate. The similarity between the results for 
the three Lewis acids indicates that same intermediate is 
formed in all of the three reactions. Probably the europium 
nitrate formed in situ acts as Lewis acid in the enolization 
of the ketones in all of the cases. 
The lanthanide nitrates is a salt of easy preparation from 
available lanthanide oxides, cheaper and more stable than 
others salts and lanthanide compounds. We have prepared 
and applied on the reaction described above nitrates of 
different metals, in order to investigate their role upon the 
reaction. The results are summarized on Table 2.
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As it can be seen on Table 2, the use of 10 mol% of 
lanthanide catalyst (entry 1-6) promoted the reaction 
between 4-chloroacetophenone and benzonitrile in the 
presence of nitric acid to give 3-(4-chlorobenzoyl)-5-
phenyl-1,2,4-oxadiazole (1) in good yield. Ytterbium 
catalyst proved to be the most effective (Table 2, entry 6). 
The product was obtained in 86% in just 1.5 h at 80 oC. The 
quantity of nitric acid was controlled to avoid the formation 
of benzoic acid from hydrolysis of benzonitrile.
Due to the excellent result obtained with Yb(NO3)3, it 
was applied for the synthesis of several 1,2,4-oxadiazole 
derivatives contained electron-withdrawing and electron-
donating substituents in the aromatic ring of ketones. The 
results are given in the Table 3.
As it was shown in Table 3, a large variety of ketones 
can be converted into the corresponding 1,2,4-oxadiazole 
compounds with good to excellent yields. All yields with 
Yb(NO3)3 were higher than those obtained using Fe(NO3)3 
as catalyst and short time reaction than those obtained by 
use Y(OTf)3.
18 The reactivity of benzonitrile was higher 
than the acetonitrile in terms of reaction time and isolated 
yield (compared compounds (1, 8), (4, 9) and (5, 10)). 










HNO3 , 80 oC
1
entry catalyst (10 mol%) time / h (1) isolated yield / %
1 Eu(OTf)3 4 80
2 Eu(dithiocarbamate)3 3.5 81
3 Eu(NO3)3 3.5 81








1 La(NO3)3 4 70
2 Nd(NO3)3 3.5 72
3 Eu(NO3)3 3.5 81
4 Gd(NO3)3 3 81
5 Er(NO3)3 1.5 83
6 Yb(NO3)3 1.5 86









HNO3 , 80 oC
Yb(NO3)3R2
2-10
entry R1 R2 time / h compounds isolated yield / %
1 F C6H5 1 2 87
2 Br C6H5 1 3 83
3 H C6H5 1.5 4 80
4 CH3 C6H5 3 5 73
5 OCH3 C6H5 3 6 54
6 NO2 C6H5 3 7 65
7 Cl CH3 2 8 50
8 H CH3 5 9 45
9 CH3 CH3 5 10 55
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Furthermore, the reaction occurred with ketones with 
electron-withdrawing and electron-donating at aromatic 
ring (Table 3, entries 4, 5 and 9) and with unsubstituted 
ring (Table 3, entries 3 and 8). This is the first time that 
3-benzoyl- and 3-acetyl-1,2,4-oxadiazole derivates with 
electron donor substituent is synthesized one-pot.
Conclusions
In conclusion, we have demonstrated the effectiveness 
of the use of lanthanide nitrates as catalyst in the one-pot 
synthesis of 3-acetyl- and 3-benzoyl-1,2,4-oxadiazole 
derivates in good yield and short reaction times, when 
compared with other reported methodologies. Additionally, 
the reaction was efficient for aromatic ketones substituted 
with electron-donating and electron-withdrawing groups 
in the aromatic ring.
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